Causes and severity of ischemic stroke in patients with symptomatic intracranial arterial stenosis - PubMed (original) (raw)

Randomized Controlled Trial

Causes and severity of ischemic stroke in patients with symptomatic intracranial arterial stenosis

Bolanle M Famakin et al. Stroke. 2009 Jun.

Abstract

Background and purpose: There are limited data on the causes and severity of subsequent stroke in patients presenting initially with TIA or stroke attributed to intracranial arterial stenosis.

Methods: We evaluated the location, type (lacunar vs nonlacunar), cause, and severity of stroke in patients who had an ischemic stroke endpoint in the Warfarin Aspirin Symptomatic Intracranial Disease (WASID) trial.

Results: Of the 569 patients enrolled in the WASID trial, 106 patients (18.6%) had an ischemic stroke during a mean follow-up of 1.8 years. Stroke occurred in the territory of the symptomatic artery in 77 (73%) of 106 patients. Among the 77 strokes in the territory, 70 (91%) were nonlacunar and 34 (44%) were disabling. Stroke out of the territory of the symptomatic artery occurred in 29 (27%) of 106 patients. Among these 29 strokes, 24 (83%) were nonlacunar, 14 (48%) were attributed to previously asymptomatic intracranial stenosis, and 9 (31%) were disabling.

Conclusions: Most subsequent strokes in patients with symptomatic intracranial artery stenosis are in the same territory and nonlacunar, and nearly half of the strokes in the territory are disabling. The most commonly identified cause of stroke out of the territory was a previously asymptomatic intracranial stenosis. Penetrating artery disease was responsible for a low number of strokes.

PubMed Disclaimer

Figures

Figure 1

Location and subtypes of endpoint ischemic strokes in the WASID study

Cited by

Stenting versus aggressive medical therapy for intracranial arterial stenosis.
Chimowitz MI, Lynn MJ, Derdeyn CP, Turan TN, Fiorella D, Lane BF, Janis LS, Lutsep HL, Barnwell SL, Waters MF, Hoh BL, Hourihane JM, Levy EI, Alexandrov AV, Harrigan MR, Chiu D, Klucznik RP, Clark JM, McDougall CG, Johnson MD, Pride GL Jr, Torbey MT, Zaidat OO, Rumboldt Z, Cloft HJ; SAMMPRIS Trial Investigators. Chimowitz MI, et al. N Engl J Med. 2011 Sep 15;365(11):993-1003. doi: 10.1056/NEJMoa1105335. Epub 2011 Sep 7. N Engl J Med. 2011. PMID: 21899409 Free PMC article. Clinical Trial.
Impact of MCA stenosis on the early outcome in acute ischemic stroke patients.
Jeng JS, Hsieh FI, Yeh HL, Chen WH, Chiu HC, Tang SC, Liu CH, Lin HJ, Hsu SP, Lo YK, Chan L, Chen CH, Lin RT, Chen YW, Lee JT, Yeh CH, Sun MH, Lai TC, Sun Y, Sun MC, Chen PL, Chiang TR, Lin SK, Yip BS, Chen CI, Bai CH, Chen ST, Chiou HY, Lien LM, Hsu CY; Taiwan Stroke Registry Investigators. Jeng JS, et al. PLoS One. 2017 Apr 7;12(4):e0175434. doi: 10.1371/journal.pone.0175434. eCollection 2017. PLoS One. 2017. PMID: 28388675 Free PMC article.
Stroke radiology and distinguishing characteristics of intracranial atherosclerotic disease in native South Asian Pakistanis.
Khan M, Rasheed A, Hashmi S, Zaidi M, Murtaza M, Akhtar S, Bansari L, Shah N, Samuel M, Raza S, Khan UR, Ahmed B, Ahmed B, Ahmed N, Ara J, Ahsan T, Munir SM, Ali S, Mehmood K, Makki KU, Ahmed MM, Sheikh N, Memon AR, Frossard PM, Kamal AK. Khan M, et al. Int J Stroke. 2013 Oct;8 Suppl A100(0 100):14-20. doi: 10.1111/j.1747-4949.2012.00878.x. Epub 2012 Sep 27. Int J Stroke. 2013. PMID: 23013556 Free PMC article.
Multiple versus fewer antiplatelet agents for preventing early recurrence after ischaemic stroke or transient ischaemic attack.
Naqvi IA, Kamal AK, Rehman H. Naqvi IA, et al. Cochrane Database Syst Rev. 2020 Aug 17;8(8):CD009716. doi: 10.1002/14651858.CD009716.pub2. Cochrane Database Syst Rev. 2020. PMID: 32813275 Free PMC article.
Indirect revascularization for nonmoyamoya intracranial arterial stenoses: clinical and angiographic outcomes.
Dusick JR, Liebeskind DS, Saver JL, Martin NA, Gonzalez NR. Dusick JR, et al. J Neurosurg. 2012 Jul;117(1):94-102. doi: 10.3171/2012.4.JNS111103. Epub 2012 May 4. J Neurosurg. 2012. PMID: 22559848 Free PMC article.

References

1. Barnett HJ, Gunton RW, Eliasziw M, Fleming L, Sharpe B, Gates P, Meldrum H. Causes and severity of ischemic stroke in patients with internal carotid artery stenosis. JAMA. 2000;283:1429–1436. - PubMed
1. Stroke prevention in atrial fibrillation study. Final results. Circulation. 1991;84:527–539. - PubMed
1. Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation: Stroke prevention in atrial fibrillation II study. Lancet. 1994;343:687–691. - PubMed
1. Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke prevention in atrial fibrillation iii randomised clinical trial. Lancet. 1996;348:633–638. - PubMed
1. Chimowitz MI, Lynn MJ, Howlett-Smith H, Stern BJ, Hertzberg VS, Frankel MR, Levine SR, Chaturvedi S, Kasner SE, Benesch CG, Sila CA, Jovin TG, Romano JG Warfarin-Aspirin Symptomatic Intracranial Disease Trial I. Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. New England Journal of Medicine. 2005;352:1305–1316. - PubMed

Causes and severity of ischemic stroke in patients with symptomatic intracranial arterial stenosis - PubMed (original) (raw)